The clinical epidemiology of sickle cell anemia In Africa.
about
Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa.Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings
P2860
The clinical epidemiology of sickle cell anemia In Africa.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The clinical epidemiology of sickle cell anemia In Africa.
@en
The clinical epidemiology of sickle cell anemia In Africa.
@nl
type
label
The clinical epidemiology of sickle cell anemia In Africa.
@en
The clinical epidemiology of sickle cell anemia In Africa.
@nl
prefLabel
The clinical epidemiology of sickle cell anemia In Africa.
@en
The clinical epidemiology of sickle cell anemia In Africa.
@nl
P2093
P2860
P50
P356
P1476
The clinical epidemiology of sickle cell anemia In Africa
@en
P2093
Alex W Macharia
Benjamin Tsofa
Carolyne M Ndila
Emily Nyatichi
George Mochamah
Gideon Nyutu
J Anthony G Scott
Johnstone Makale
Kennedy O Awuondo
Metrine Tendwa
P2860
P304
P356
10.1002/AJH.24986
P577
2017-11-23T00:00:00Z